






License: Article 25fa pilot End User Agreement 
This publication is distributed under the terms of Article 25fa of the Dutch Copyright Act (Auteurswet) 
with explicit consent by the author. Dutch law entitles the maker of a short scientific work funded either 
wholly or partially by Dutch public funds to make that work publicly available for no consideration 
following a reasonable period of time after the work was first published, provided that clear reference is 
made to the source of the first publication of the work.  
This publication is distributed under The Association of Universities in the Netherlands (VSNU) ‘Article 
25fa implementation’ pilot project. In this pilot research outputs of researchers employed by Dutch 
Universities that comply with the legal requirements of Article 25fa of the Dutch Copyright Act are 
distributed online and free of cost or other barriers in institutional repositories. Research outputs are 
distributed six months after their first online publication in the original published version and with proper 
attribution to the source of the original publication.  
You are permitted to download and use the publication for personal purposes. All rights remain with the 
author(s) and/or copyrights owner(s) of this work. Any use of the publication other than authorised under 
this licence or copyright law is prohibited. 
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, 
please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make 





Rodebaugh T.L., Tonge N.A., Piccirillo M.L., Fried E.I., Horenstein A., Morrison A.S., Goldin P., 
Gross J.J., Lim M.H., Fernandez K.C., Blanco C., Schneier F.R., Bogdan R., Thompson R.J. & 
Heimberg R.G. (2018), Does centrality in a cross-sectional network suggest intervention targets 
for social anxiety disorder?, Journal of Consulting and Clinical Psychology 86(10): 831-844.  
Doi: 10.1037/ccp0000336 
Does Centrality in a Cross-Sectional Network Suggest Intervention Targets
for Social Anxiety Disorder?
Thomas L. Rodebaugh, Natasha A. Tonge,
and Marilyn L. Piccirillo








University of California, Davis
James J. Gross
Stanford University
Michelle H. Lim and Katya C. Fernandez
Washington University in St. Louis
Carlos Blanco and Franklin R. Schneier
Columbia University
Ryan Bogdan and Renee J. Thompson
Washington University in St. Louis
Richard G. Heimberg
Temple University
Objective: Network analysis allows us to identify the most interconnected (i.e., central) symptoms, and
multiple authors have suggested that these symptoms might be important treatment targets. This is
because change in central symptoms (relative to others) should have greater impact on change in all other
symptoms. It has been argued that networks derived from cross-sectional data may help identify such
important symptoms. We tested this hypothesis in social anxiety disorder. Method: We first estimated a
state-of-the-art regularized partial correlation network based on participants with social anxiety disorder
(n  910) to determine which symptoms were more central. Next, we tested whether change in these
central symptoms were indeed more related to overall symptom change in a separate dataset of
participants with social anxiety disorder who underwent a variety of treatments (n  244). We also tested
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whether relatively superficial item properties (infrequency of endorsement and variance of items) might
account for any effects shown for central symptoms. Results: Centrality indices successfully predicted
how strongly changes in items correlated with change in the remainder of the items. Findings were
limited to the measure used in the network and did not generalize to three other measures related to social
anxiety severity. In contrast, infrequency of endorsement showed associations across all measures.
Conclusions: The transfer of recently published results from cross-sectional network analyses to
treatment data is unlikely to be straightforward.
What is the public health significance of this article?
Researchers have recently asserted that network analyses might uncover the most important symp-
toms to target in treatment, even when the data used were collected at a single time point. We
examined this issue in generalized social anxiety disorder and found modest support for the notion.
However, simply counting how many participants endorsed the symptom as clearly present was a
superior method for identifying important symptoms.
Keywords: network analysis, social anxiety disorder, research methods
Supplemental materials: http://dx.doi.org/10.1037/ccp0000336.supp
Many studies of psychopathology seem to assume what might
be called a common cause perspective. This approach involves
thinking of clinical symptoms largely as passive measurements of
an underlying mental disorder. Thus, a person has anxiety and
avoidance about a variety of social situations as a consequence of
having social anxiety disorder (SAD). From this viewpoint, the
important causes and consequences are those related to the under-
lying latent variable of SAD itself, rather than to specific symp-
toms of SAD. Multiple authors have recently proposed that net-
work perspectives offer an important alternative to a common
cause perspective (Borsboom & Cramer, 2013; Borsboom et al.,
2016; Cramer, Waldorp, van der Maas, & Borsboom, 2010a,
2010b; Fried et al., 2017; McNally et al., 2015).
In a network conception, symptoms are understood as poten-
tially causal agents in their own right (Borsboom, 2008; Bors-
boom, 2017). Instead of SAD being an entity to study, it could
simply be a label for a set of symptoms (or other factors) that cause
each other over time. A large number of authors have suggested
that both the network conception and its related analyses could
help researchers uncover central, important, or key symptoms that
may provide viable treatment targets (Borsboom & Cramer, 2013;
Borsboom, Cramer, Schmittmann, Epskamp, & Waldorp, 2011;
Bringmann et al., 2013, 2016; Cramer et al., 2010a; Fried et al.,
2016; McNally et al., 2015; Robinaugh, LeBlanc, Vuletich, &
McNally, 2014; Ruzzano, Borsboom, & Geurts, 2015; van de
Leemput et al., 2014; Wichers, 2014; Wichers, Groot, & Psycho-
systems, ESM Group, & EWS Group, 2016).
One can distinguish a network theory of psychopathology from
network psychometrics—the statistical techniques used to estimate
network models. These network analyses, like any other statistical
technique, can be applied in a variety of ways to a variety of types
of data. Many network analyses presented in the literature have
focused on cross-sectional data (with some notable exceptions;
see, e.g., Bringmann et al., 2013). Multiple authors have suggested
that treatment of the symptoms identified as the most important in
cross-sectional network analyses may result in the greatest overall
treatment gains (McNally et al., 2015; Ruzzano et al., 2015). The
implication is that cross-sectional network analyses might identify
important treatment targets.
Figure 1 provides an example of a quantitative indicator of
network importance, the centrality index strength. In this network,
nodes (e.g., symptoms or items) are represented by circles, and the
strength of the relationships between nodes is depicted by the
thickness of the lines between the nodes that are called edges. In
Figure 1. Example network demonstrating hypothetical relationships be-
tween nodes. The relationships between Nodes 1 have been arranged so
that Node 1 has a higher value for strength (i.e., stronger correlations with
Nodes 2–6 as indicated by thicker lines; strength  .81) All other nodes
have weaker strength in this example; Node 2 (strength  .54) is the next







































































































832 RODEBAUGH ET AL.
the type of graphs typically presented (e.g., in the literature cited
above), the nodes are positioned based on the strength of their
relationships with other nodes. In Figure 1, the nodes have varied
properties, with Node 1 having the greatest strength in its edges
with other nodes, where strength is defined as the sum of all
absolute edge weights connected to a node. Strength is one of
many centrality indices; we also investigate closeness and be-
tweenness in this article. As is hopefully clear from Figure 1,
centrality is not always easily determined by visually inspecting a
graph: Although Node 1 has the greatest strength, it is not literally
at the center of the figure. This is because centrality indices are
inferences of high-dimensional network structures that cannot al-
ways be mapped in two dimensions in an ideal way and therefore
may not correspond obviously to visual cues (e.g., such as how
close to the center a node is).
The idea that centrality indices should identify symptoms that
are important for treatment rests upon the inference that centrality
indices, by identifying symptoms with strong quantitative relation-
ships with others, also identify those symptoms with a strong
causal role during treatment. That is, consider Node 1 in Figure 1.
It has a strength index of .81, whereas all other nodes in the figure
have lower strength values (Node 2 has the second highest value,
at .54). If the edges shown involve causal relationships directed
from Node 1 to other nodes, then a change in Node 1, compared
the same amount of change in the other nodes, would be expected
to produce the strongest changes in the other nodes (all other
factors being equal).
The intuitive appeal of the idea that high centrality involves high
causal impact is clear, but changing Node 1 may do nothing if the
high strength of its associated edges are entirely produced by other
nodes causing Node 1. Similarly, an edge between Nodes 1 and 2
can result from failing to include important variables in the net-
work that covary with both, in which case changing Node 1 may
not have an impact on Node 2. More generally, the question of
whether and how cross-sectional relationships in complex models
are related to causality over time is a contentious one. Among the
authors of the current article, for example, there are a wide variety
of viewpoints on this issue. Some of us view models based on
cross-sectional data as a first step, useful for initial testing of
theories that may or may not generalize to other types of data. All
of us agree at least on the idea that a cross-sectional relationship
between two variables implies some shared causal path that in-
volves those two variables (even if the shared path is that a third
variable causes both). At the same time, some of us find it
implausible that there will be any systematic correspondence be-
tween cross-sectional data and either experimental or longitudinal
data and point to such findings of those of Maxwell and Cole to
support this pessimism (Cole & Maxwell, 2003; Gollob & Reich-
ardt, 1987; Maxwell & Cole, 2007; Maxwell, Cole, & Mitchell,
2011).
For central symptoms to be reliably important for treatment,
centrality must have a high tendency to signal cause and effect in
some form: A symptom is key to treatment if changing that
symptom causes an important effect on other symptoms. This
situation raises an empirical question: What relation is there, if
any, between central symptoms identified in a cross-sectional
network and change in other symptoms across treatment? The
current article aims to answer this question in the context of SAD
treatment.
Looking at the prior literature on the topic, there are two
especially relevant papers that came to opposite conclusions. One
study, focusing on depression symptoms, examined whether cen-
trality (measured by strength) estimated from a cross-sectional
network predicted strength in individual person-level networks
across time (Bos et al., 2017). These authors found no evidence
that cross-sectional centrality indices clearly signal how much
nodes predict other nodes over time. However, the sample was
relatively small for a network analysis (n  104), and no infor-
mation was provided regarding the stability of the centrality esti-
mates.
In a second study, Robinaugh and colleagues (Robinaugh, Mill-
ner, & McNally, 2016) demonstrated that, in a group of older
adults observed naturalistically, symptoms identified as more cen-
tral to the network at a single time point appeared more clearly
connected to change in other symptoms over time. That is, Ro-
binaugh and colleagues computed how much change in an item
correlated with change in the remaining items, and then examined
whether that item’s centrality was associated with that correlation.
Returning to the example in Figure 1, when Node 1 changes, how
much it changes should be highly correlated with how much the
other nodes change (due to its high strength in the network), if
indeed the edges radiating from Node 1 are related to causal
pathways.
The results from this naturalistic study could be extended to the
context of treatment. If symptoms identified as more central in
cross-sectional data are indeed more important in predicting
change in other symptoms across treatment as well, then change in
these symptoms should be strongly associated with change in the
entire network. For example, take SAD as a set of clinical symp-
toms involving fear and avoidance of social situations. If fear of
one type of social situation, such as talking with authority figures,
were found to be more central in a cross-sectional network, change
in fear of talking with authority figures across treatment should
relate strongly to changes in fear and avoidance of other situations.
That is, if centrality in a cross-sectional network corresponds to
importance for treatment, then change in the more central symp-
toms—whether they were targeted or not—should be a particularly
good predictor of change in the rest of the network. Further,
changes in these more central symptoms might also show stronger
relationships with changes in other symptom measures, demon-
strating their potential causal importance not only within the
network, but also outside of the modeled network, in a similar
realm of symptoms (and thus potentially within the same concep-
tual network). To the best of our knowledge, such a test has not yet
been published in the literature.
We thus investigated whether symptoms identified as more
central to a cross-sectional network of social anxiety symptoms
(from the Liebowitz Social Anxiety Scale [LSAS]; Liebowitz,
1987) showed evidence of being important for change during
treatment. We used one sample to obtain centrality indices and a
second sample to examine change across treatment, approximating
a clinician’s application of results from the literature; however, we
also examined whether estimating the network based on the pre-
treatment data made any difference. We examined change both
within the LSAS network and outside of the modeled network (i.e.,
by focusing on other measures of social anxiety severity). We
hypothesized that change in items with higher centrality (vs. those






































































































833CENTRALITY FROM CROSS-SECTIONAL NETWORKS
change both within the LSAS network and in additional measures
of social anxiety severity. We also expected the strongest relation-
ships to be found within the LSAS network (due, e.g., to the
common finding of stronger correlations within a measure than
across measures). Finally, we tested whether item properties (i.e.,
infrequency of endorsement, item variance) with no obvious causal
properties might account for any findings related to centrality.
These latter tests are important because centrality indices can be
affected by item properties such as rates of endorsement (Terluin,
de Boer, & de Vet, 2016). Because we were concerned about the
ability to predict decreases in symptoms across treatment, we were
most concerned with restriction of range (i.e., variance) and floor
effects (i.e., infrequency of endorsement). That is, an item, even if
it measures an important causal factor, will have difficulty asso-
ciating with reductions across treatment if that item lacks sufficient
range or lacks sufficient numbers of participants who endorse it
prior to treatment. We will refer to variance and infrequency of
endorsement collectively as relatively superficial item properties;
we mean by this phrase not that they are unimportant, but that
these are properties that are relatively easy to manipulate (e.g., by
changing the response scale) without changing the property we
believe is being measured.
Method
Participants
Participants with generalized social anxiety disorder were pooled
from several archival data sets. All participants provided informed
consent for their data to be collected as part of a research project
approved by the appropriate institutional review board. Data sets were
examined as two samples. The first sample (Sample A) was used to
estimate the cross-sectional network, whereas in the second (Sample
B), we examined change across treatment. The two samples did not
differ in regard to age or gender (ps  .138) but did differ by ethnicity
in that Asian Americans were more well-represented in the treatment
sample, 2(1, N  605)  126.08, p  .001. Our intent in using the
two samples was to simulate what would happen if an existing
cross-sectional network analysis were used as a guide in a new
treatment sample; as such, some differences between the samples are
expected. However, we also examined in follow-up tests whether
conclusions were different if centrality indices were drawn from the
treatment sample instead.
Network analysis sample (Sample A). A total of 910 partic-
ipants diagnosed with DSM–IV (American Psychiatric Associa-
tion, 1994) generalized social anxiety disorder (GSAD) via struc-
tured clinical interview were included in Sample A. These data
were drawn from nine separate data sets that had been collected as
part of several studies conducted at metropolitan and urban re-
search centers. Overall characteristics of the sample, including
demographics, are displayed in Table 1 (full details of each sub-
sample are available in the online supplemental material). All
participants completed the clinician-administered version of the
LSAS. In all cases, only pretreatment data were used, although
most participants were in studies including treatment.
Treatment sample (Sample B). An additional, nonoverlap-
ping sample of 244 participants was included in analyses fo-
cused on treatment; a total of 155 participants provided at least
some data at posttreatment. Participants were recruited for three
treatment studies that included cognitive– behavioral therapy,
mindfulness-based stress reduction, aerobic exercise, and wait
list conditions (see the online supplemental material for full
information). Participants were diagnosed with GSAD or SAD
via a structured clinical interview, and the data were maintained
in three separate data sets that were collected from a large, West
coast university located outside a metropolitan area. All partic-
ipants completed a self-report version of the LSAS. Participant
characteristics are provided in Table 2 (additional details are
provided in the online supplementary material).
Table 1
Frequencies and Descriptive Statistics From Sample A and Sample B
Variable Sample A (n  910) Missing n (%) Sample B (n  244) Missing n (%)
Age (years), M (SD) 33.96 (12.10) 2 (.22) 33.13 (8.33) 4 (1.64)
Female, n (%) 398 (43.74) 33 (3.63) 126 (51.64) 3 (1.23)
Race and Ethnicity, n (%)a 303 (33.30) 3 (1.23)
Caucasian 363 (39.89) 116 (47.54)
African-American 124 (13.63) 2 (.82)
Asian or Pacific Islander 36 (3.96) 87 (35.66)
American Indian or Alaska Native 7 (.77) 1 (.41)
Multiracialb 9 (.99) 14 (5.74)
Unlisted racial minority 15 (1.65) 0 (.00)
Hispanic 53 (5.82) 21 (8.61)
LSAS total, M (SD)c 78.31 (38.82) 38 (4.18) 88.04 (17.82) 17 (7.00)
LSAS total, posttreatment, M (SD) 51.71 (21.50) 81 (33.20)
Note. LSAS  Leibowitz Social Anxiety Scale.
a For 221 (24.30%) of the participants in Sample A and for 130 (53.30%) of the participants in Sample B, Hispanic ethnicity was assessed as an option
when reporting race, rather than assessed separately as part of ethnicity. Thus, we are missing additional racial information on participants who chose to
select the Hispanic option when reporting their race. The frequency for Hispanic represents to the frequency of participants who endorsed Hispanic ethnicity
plus a racial category in addition to the frequency of participants who endorsed Hispanic ethnicity when it was assessed as a racial category. The frequency
for missing represents the frequency of participants who were missing all racial or ethnic data. We did not include the frequency of participants who reported
Hispanic ethnicity but who were missing additional racial information in this estimate. Percentages do not add precisely to 100 due to round-
ing. b Multiracial was provided as an option for only 125 (13.70%) of the participants in Sample A. c The LSAS total score represents the pre-treatment
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Measures
LSAS: Clinician-Administered Version. The LSAS: Clinician-
Administered Version (LSAS-CA; Liebowitz, 1987) is a 48-item
clinician-administered measure that assesses social fear and avoid-
ance across 24 separate social performance and interaction situa-
tions. Clinicians instruct individuals to report their level of fear and
avoidance of the given situation during the past week using a
4-point Likert-type scale. The fear scale ranges from 0 (none) to 3
(severe) and the avoidance scale ranges from 0 (never) to 3
(usually). The LSAS-CA has demonstrated excellent internal con-
sistency, as well as strong convergent validity with other clinician-
administered and self-report measures of social anxiety and diver-
gent validity with measures of depression (Heimberg et al., 1999;
Heimberg, Mueller, Holt, Hope, & Liebowitz, 1992). The
LSAS-CA was used in Data Sets 1–9 (i.e., Sample A). The internal
consistency for the items composing the total score was excellent
(  .98).
LSAS: Self-Report Version. The self-report version of the
LSAS (LSAS-SR; Fresco et al., 2001) uses the same situations and
scales as the LSAS-CA. Instructions for the LSAS-SR are adapted
from the LSAS-CA and are provided at the top of the measure for
the participant to review as necessary. The LSAS-SR was used
in Sample B. For one of the three treatment studies, as well as
at follow-up time-points for the two other treatment studies, the
LSAS-SR was delivered online. Previous studies have demon-
strated that the LSAS-SR and its subscales have good internal
consistency and the total score from the LSAS-SR is strongly
correlated with total score from the LSAS-CA, r  .85, p  .05
(Baker, Heinrichs, Kim, & Hofmann, 2002; Fresco et al., 2001;
Oakman, Van Ameringen, Mancini, & Farvolden, 2003). The
internal consistencies for items composing the total score pre-
and posttreatment were excellent (  .91 and .95, respec-
tively).
Social Interaction Anxiety Scale—Straightforward items.
The Social Interaction Anxiety Scale—Straightforward items
(SIAS-S; Rodebaugh, Woods, & Heimberg, 2007) is modified
from the original SIAS that was developed by Mattick and Clarke
(1998) and includes the 17 straightforward items from the original
20-item scale. The items assess social anxiety in various social
interaction situations. The SIAS-S uses a 5-point Likert-type scale
ranging from 0 (not at all) to 4 (extremely) to assess level of social
anxiety in a given situation. The SIAS-S has demonstrated a
unifactorial structure with high internal consistency (Rodebaugh et
al., 2007; Rodebaugh, Woods, Heimberg, Liebowitz, & Schneier,
2006). Furthermore, it has displayed strong construct validity in
both undergraduate and clinical samples, as well as strong conver-
gent validity with other measures of social anxiety and divergent
validity with other psychological or personality constructs (Rode-
baugh et al., 2007, 2011).
Brief Fear of Negative Evaluation Scale—Straightforward
items. The Brief Fear of Negative Evaluation Scale—Straightforward
items (BFNE-S; Rodebaugh et al., 2004) is modified from the
original 12-item BFNE that was developed by Leary (1983) and
includes only the eight straightforwardly worded items. The
BFNE-S uses a 5-point Likert-type scale ranging from 1 (not at
all characteristic of me) to 5 (extremely characteristic of me).
Psychometric studies have suggested that the eight straightfor-
ward items of the scale, as compared to the four reverse-scored
items or the entire BFNE, demonstrate the strongest reliability
and validity (Carleton, Collimore, McCabe, & Antony, 2011;
Rodebaugh et al., 2004, 2011; Weeks et al., 2005).
Sheehan Disability Scale. The Sheehan Disability Scale (SDS;
Sheehan, 1983) is a three-item measure that assesses the degree to
which an individual’s symptoms affect their work, social, and
home life. The items are measured using a 10-point visual analog
scale that ranges from 0 (not at all) to 10 (extremely), and total
scores range from 0 (no impairment) to 30 (significant impair-
ment). The SDS has demonstrated a unifactorial structure with
acceptable internal consistency (Leon, Shear, Portera, & Klerman,
1992). It has been demonstrated to discriminate between those who
are experiencing psychiatric symptoms and those who are symp-
tom free, suggesting good construct validity (Leon, Olfson, Por-
tera, Farber, & Sheehan, 1997; Leon et al., 1992; Olfson et al.,
1997). Among people with SAD, the SDS has also shown signs of
good validity and modest internal consistency, although longer
scales measuring disability perhaps unsurprisingly showed stron-
ger properties (Hambrick, Turk, Heimberg, Schneier, & Liebowitz,
2004).
Data Analytic Procedure
A priori tests versus revised analyses. We originally exam-
ined all 48 of the LSAS items (24 fear and avoidance situations) in
Table 2
Multiple Regression Results (Part rs) for Centrality Indices
Main analyses (no correction) Main analyses (corrected) Added participants
Predictor LSAS SIAS-S BFNE-S SDS LSAS SIAS-S BFNE-S LSAS SIAS-S BFNE-S SDS
Centrality composite .48 .02 .11 .18 .40 .25 .16 .44 .01 .03 .20
Infrequency .50 .68 .65 .72 .55 .54 .78 .26 .57 .56 .55
Variance (SD) .31 .14 .24 .15 .09 .22 .02 .02 .18 .13 .16
Note. These regressions were run using the data that can be found in Table S1 in the online supplementary material. Each column heading lists the
dependent variable, which in each case is the correlation between change in a node and the change in the measure listed. In each regression, all of the
predictors were included. Main Analyses  Initial analysis with Sample A centrality indices. Coefficient under the (No Correction) heading is before
correction by removing nodes with excessive SDBetas; coefficient Under the (Corrected) heading (if any) is after correction. The SDS analysis did not
require correction. Added Participants  Sample A with participants who did not have generalized social anxiety disorder included. LSAS  Liebowitz
Social Anxiety Scale; SIAS-S  Social Interaction Anxiety Scale-Straightforward; BFNE-S  Brief Fear of Negative Evaluation-Straightforward; SDS 
Sheehan Disability Scale; Centrality Composite  combined strength and closeness.






































































































835CENTRALITY FROM CROSS-SECTIONAL NETWORKS
a network. However, as pointed out during the review process, the
covariance matrix of the symptoms was not positive definite,1
presumably because of high collinearity between anxiety and
avoidance ratings of each situation. Thus, we investigated the
anxiety and avoidance items separately. We examined three com-
monly used centrality measures: betweenness, centrality, and strength.
We determined that centrality indices were moderately to highly
correlated across the two items sets (betweenness: rs  .38–.43,
ps  .006–.06; closeness: rs  .43–.46, ps  .025–.037; strength:
rs  .85–.89, ps  .001; note that strength was the most stable
index in each set of items). We therefore decided to add anxiety
and avoidance items together for each situation. In addition to
adding together anxiety and avoidance items across situations, we
observed that two situations were not only very similar in concept,
but also so highly correlated as to suggest that they were measur-
ing the same construct: talking to people you do not know very
well and meeting strangers (fear: r  .61; avoidance: r  .64); and
performing in front of an audience and giving a report to a group
(both fear and avoidance: rs  .77). Treating these situations as
separate could produce nonsensical estimates in the same manner
that would occur if one ran a regression with two highly correlated
measures of anxiety included as separate predictors. We therefore
additionally summed the two highly correlated situation pairs to
generate 22 nodes for analysis. Finally, we rescaled the two nodes
drawn from four items by using the cut function in R (R Core
Team, 2017) to reproduce the same 0–6 scale of all other nodes.
The a priori analyses we originally conducted were predicated
on the assumption that there would be a set of items that either
clearly had higher centrality than all others or were at least more
stable in their high centrality than others. In the revised analyses,
this was no longer the case. Accordingly, we adopted the method
used by Robinaugh et al. (2016). Although this is not the method
we had selected a priori, it is suitable for the situation in the revised
data, in which the nodes all have fairly stable rankings in terms of
centrality and no small set of nodes is clearly higher in centrality
than the others.
Revised analyses. Here we focus on the overall plan for the
analyses (more detailed information on each aspect of the data
analytic procedure is available in the online supplemental materi-
als). We first created five multiple imputation data sets from
Sample A to handle sporadic missing data, using random forest
imputation. A total of 11% of participants with GSAD in Sample
A had at least some missing data. Because there is no best standard
for how to deal with multiply imputed data in network analyses,
we focused on consistent findings across all five data sets. Fol-
lowing the compositing described above (resulting in 22 nodes),
network estimation and network stability tests were conducted in
accordance with current standards using R packages qgraph (Ver-
sion 1.4.1; Epskamp, Cramer, Waldorp, Schmittmann, & Bors-
boom, 2012) and bootnet (Version 0.3; Epskamp, Borsboom, &
Fried, 2018), respectively. See online supplementary materials for
information on all R packages used. An undirected regularized
partial correlation network was estimated, resulting in edges that
can be interpreted as partial correlation coefficients (an association
between two items controlling for all other associations among
items). Regularization ensures that the estimated network structure
balances sensitivity with specificity and leads to a sparse network
structure that avoids obtaining spurious edges (Epskamp & Fried,
in press). We determined which centrality indices to consider
further based on their correlation stability coefficient estimated in
bootnet. Indices were determined to be stable if at least 25% of the
cases could be removed and the order of nodes maintained a
correlation of 0.7 (with 95% probability) with the original sample
(see Epskamp et al., 2018, for a description of the correlation
stability coefficient). To ensure that results were not due to relative
superficial item properties that can bias centrality indices, we also
examined frequency of endorsement (i.e., floor effects) and stan-
dard deviation (i.e., effects for the range of the item; cf. Terluin et
al., 2016). Infrequency was defined as the number of participants
who scored 0 on that node (with nodes values ranging from 0 to 6);
notably, a score of 0 would indicate the participant endorsed a 0 on
all of the items that ultimately comprised that node. The standard
deviation was simply the SD for that node.
Following the method used by Robinaugh and colleagues (2016)
we then examined centrality indices across nodes. The outcomes of
interest were the degree to which change in a given node correlated
with change, from Sample B, in (a) the remainder of the LSAS
items, (b) the SIAS-S items, (c) the BFNE-S items, and (d) the
SDS items. For (a), the remainder of the LSAS items were defined
as the total of the items minus the investigated node. Again, the
notion is that, for each outcome, higher centrality should be
associated with a higher correlation between change in that node
and change in the outcome. Note that because some participants
dropped out of treatment or did not provide the given measure, we
obtained these correlations pairwise; each correlation was esti-
mated using between 133 and 155 cases. To determine whether
any correlations might be better explained by relatively superficial
item properties, we also conducted multiple regressions in which
centrality and item properties were included as predictors. When
conducting multiple regressions, we examined the correlations
between the centrality indices and composited them if correlations
were high (e.g., .50) because the intent was to assess the use-
fulness of centrality indices rather than pit them against each other.
We also examined the SDBeta statistic, which identifies items
that are overly influential, such that their removal would have a
strong impact on the regression coefficient. We considered this test
essential given the small sample size for these analyses (i.e., 22
nodes). We report below when we removed nodes that had an




We first estimated the overall network structure for each of the
five imputations of Sample A. Figure 2 displays the results for the
first imputed dataset; the (very similar) figures for the other
imputed data sets are presented in online supplementary material
(Figures S1 and S2). The results presented below were across all
of the imputed data sets, and not simply the first one. We examined
the centrality stability indices for strength, closeness, and between-
ness to determine which metrics were appropriate for further
analysis. Using the cut-off of 0.25 suggested by simulation studies







































































































836 RODEBAUGH ET AL.
(Epskamp et al., 2018), we determined that strength (conditional
stimulus (CS) [cor  0.7]  .59–.67) and betweenness (CS [cor 
0.7]  .28) were sufficiently stable across imputations to justify
use in subsequent analyses. Strength refers to how strongly a node
relates to other nodes, whereas betweenness refers to how impor-
tant a node is in paths between other nodes (cf. Epskamp et al.,
2018). Another centrality index, closeness, was less stable (CS
[cor  0.7]  .21–.28) and we refrain from interpreting it in the
primary analyses.
Treatment Response Prediction
Within-LSAS-network prediction. In the within-network
prediction, the test was whether centrality indices predicted the
correlation between change in a node and change in the rest of
the network. We will call the dependent variable for this set of
analyses node–LSAS change correlation. Notably, these analy-
ses were conducted with nodes as the unit of analysis and not
people: Values for the nodes were obtained from Sample A (for
centrality and item properties) and Sample B (for correlations).
Because the data analyzed were by node, the entire dataset is
represented in Supplemental Table S1 in the online supplemen-
tary material.
As hypothesized, both strength, r  .48, p  .026 and betweenness,
r  .53, p  .011 were related to the node-LSAS change correlation.
This finding indicates that the centrality indices successfully identified
nodes for which their change was more strongly associated with
change in the rest of the network. Because strength and betweenness
were strongly correlated, r  .66, p  .001, they were z-scored and
composited for remaining analyses (and referred to as the centrality
composite). We did this because entering them as individual predic-
Figure 2. Network model of Liebowitz Social Anxiety Scale items. The figure displays the network for the first
of the five imputed data sets; network models of all five imputations can be found in the supplement. The blue
(darker gray) solid lines represent positive relations, whereas the red (lighter gray and dashed) lines represent
negative relations between items. Nodes of items numbered 1 through 24 refer to fear or anxiety of a given
situation and avoidance of the same situation. Note that Item Pairs 6 and 20 and 11 and 12 have been combined
into a single node due to high correlations between these items pairs. The situations represented are, in brief (i.e.,
not verbatim): 1  public telephone use, 2  small groups, 3  eating in public, 4  drinking in public, 5 
talking to authority figures, 6  acting, performing, giving a talk, 7  going to a party, 8  working while
observed, 9  writing while observed, 10  calling a relatively unknown person, 11  talking to a relatively
unknown person, 12  meeting strangers, 13  urinating in a public restroom, 14  entering a room where
others are seated, 15  center of attention, 16  commenting during a meeting, 17  taking test, 18 
expressing disagreement to relatively unknown person, 19  looking relatively unknown person in the eyes,
20  report to group, 21  asking someone on a date, 22  returning goods, 23  giving party, 24  resisting






































































































837CENTRALITY FROM CROSS-SECTIONAL NETWORKS
tors would lead to a focus on their unique properties, whereas we were
interested in centrality overall.
Infrequency of item endorsement, r  .61, p  .003 was also
strongly associated (whereas node SD was not: r  .04, p  .874)
with the node-LSAS change correlation. Further, strength and
betweenness showed a pattern of correlations with infrequency and
variance that might indicate that this association partially ex-
plained their relationship to change (e.g., the centrality compos-
ite’s correlation with infrequency was .30, p  .179; with SD,
r  .48, p  .025). To determine the relative strength of prediction
for these associations, the three node properties (centrality com-
posite, infrequency, and SD) were entered in a regression equation
predicting the node-LSAS change correlation. The coefficients for
these analyses are presented in Table 2. All three predictors were
statistically significant. Notably, the result for SD showed the
opposite sign of what was expected (suggesting statistical suppres-
sion) and did not survive correction for nodes with excessive
SDBeta values (see Table 2). Thus, both the centrality composite
and infrequency identified nodes with a stronger relationship with
change in other items. When items with higher centrality changed,
other LSAS items were more likely to change in comparison to
when lower centrality items changed. In addition, when items that
were infrequently endorsed changed, other LSAS items were less
likely to change in comparison to when items that were more
frequently endorsed changed.
Outside LSAS-network prediction of social anxiety severity.
We next repeated the analyses conducted above for three measures
not included in the LSAS network. More specifically, the question
was how strongly centrality (from Sample A) predicted how
change in a given node correlated with change in the social anxiety
severity measure in question (from Sample B). Examining zero-
order correlations, betweenness displayed at best marginal rela-
tionships (SIAS-S: r  .18, p  .451; BFNE-S: r  .19, p  .388,
SDS: r  .38, p  .079), and neither strength nor the centrality
composite showed any sign of predicting (ps  .10). Infrequency
strongly predicted across measures (SIAS-S: r  .68, p  .001;
BFNE-S: r  .73, p  .001, SDS: r  .78, p  .001). In
contrast, SD showed no relationship (ps  .23). Multiple regres-
sions are shown in Table 2 and are consistent with zero-order
correlations: Only infrequency predicted strength of association in
the additional social anxiety severity measures.2
Follow-Up Tests
Rationale. Although there was some support for the hypoth-
esis that highly central nodes predict more change in other nodes,
infrequency of endorsement was a much more robust predictor.
Three explanations for this pattern presented themselves (that are
not mutually exclusive). First, the Sample A network indices may
have been influenced by relatively superficial item properties.
Second, the Sample A network might not be consistent with the
network structure for Sample B. Third, the fact that participants all
had GSAD might produce a distorted network structure because
participants were selected based in part on properties of the net-
work (i.e., people with GSAD typically have higher LSAS scores
than those without). We attempted to address each concern below
to determine whether addressing these concerns (a) reduced effects
for infrequency or (b) increased effects for centrality. The inter-
ested reader can rerun these analyses using the data provided in
Supplemental Table S1 in the online supplementary material.
Ising network. We addressed the first problem by reducing
the probability that infrequency was having an effect on centrality
indices. We dichotomized all nodes in Sample A using a median
split of each node such that responses below the median were
coded as 0. In cases where the median was 0, responses of 0 and
1 were coded as 0 instead. This procedure minimizes the effect of
variance and infrequency (as well as all other relatively superficial
item properties) on network estimation, because most had equiv-
alent numbers of participants who endorsed 0. We then conducted
the same analyses described above using the centrality indices
from an Ising network. We investigated strength and closeness
because these indices had interpretable levels of stability in four of
five imputed data sets; none of the indices from the Ising network
had acceptable stability across all five imputed data sets. Because
the two indices were highly correlated, r  .81, p  .001, they
were composited and combined for analysis. Substantive results
for this centrality composite were identical to those reported
above; it predicted regarding the LSAS (part r  .45, p  .012,
corrected for SDBeta) but not other measures (ps  .30); infre-
quency predicted for all (ps  .008). Dichotomizing items and
thereby addressing relatively superficial item properties did not
consistently change the pattern of results, making it unlikely that
relatively superficial item properties account for the results ob-
tained.
Correspondence of centrality indices between cross-
sectional and treatment data. To address the second problem,
that the results from Sample A might vary widely from the results
Sample B (i.e., the treatment sample itself), we repeated the
procedure we used for Sample A in Sample B. Of the centrality
indices, none showed acceptable stability in these data; however,
strength was the most stable metric (CS [cor  0.7]  .21).
Strength from the pretreatment and cross-sectional data showed
reasonably good correspondence across data sets (r  .61, p 
.003; two-way random ICC for the single measure  .57, p  .002,
95% CI [.21, .80]). The entire correlation matrix of the centrality
indices is provided in Supplemental Table S2 in the online sup-
plemental material. We then repeated the multiple regressions, this
time using strength, infrequency, and variance from Sample B.
There were no significant predictors for the LSAS (ps  .06 after
correction for SDBetas). For the other measures, strength did not
predict (ps  .21), whereas infrequency predicted for the SIAS-S
2 Given this unexpected result, we also checked in Sample B itself to be
sure that change on the LSAS, SIAS-S, BFNE-S, and SDS were correlated:
They were rs  .35, ps .001, and ns  133. We also checked whether
changes in at least some nodes were correlated with changes in the SIAS-S,
BFNE-S, and SDS; this was also true, with each measure having multiple
nodes for which changes were correlated at a level of p  .001. This result
was therefore not due to the LSAS failing to correlate with other measures,
either on the level of the entire LSAS or the individual nodes. On a related
note, Sacha Epskamp, who provided a signed review, pointed out that even
if no casual process over time were involved in regard to the LSAS scores,
centrality might predict in the manner seen here due merely to regression
towards the mean. This is obviously an essential point, but one we were not
able to address adequately here. We encourage further exploration (via
mathematical proof, simulation, and experimental manipulation) of under
what conditions centrality indices should be expected to identify nodes that







































































































838 RODEBAUGH ET AL.
and BFNE-S (ps  .03) but not the SDS (p  .094; all ps
correcting for SDBetas). Relying on Sample B produced more
mixed results that showed no increased effects for centrality indi-
ces.
Addition of participants without GSAD. We added partici-
pants to Sample A who were diagnosed using the same procedures
as the GSAD participants, but who were either recruited as normal
control participants or who did not meet for GSAD diagnosis
despite expectations from screening that they would. A total of 197
participants were added to Sample A. We then reran the original
procedures and extracted centrality indices from this larger dataset.
Strength (CS [cor  0.7]  .59–.67) and betweenness (CS [cor 
0.7]  .28–.36) showed acceptable stability in all imputations,
whereas closeness did not (CS [cor  0.7]  .21–.28). The
correlation table for all three centrality indices from the larger
versus smaller cross-sectional dataset is provided in Supplemental
Table S2 in the online supplemental material; strength and be-
tweenness were strongly correlated, r  .78, p  .001, and were
therefore standardized and combined. This centrality composite,
infrequency, and SD from the expanded sample were used as
competing predictors in a multiple regression. The results from
these analyses are presented in Table 2 because it presented the
only instance in which infrequency demonstrated reduced effects.
For the LSAS, only centrality predicted strength of association. In
contrast, for the SIAS-S, BFNE-S, and SDS, only infrequency
predicted strength of association and the other predictors did not.
From the above results, it was unclear whether the apparent
improvement in the prediction by centrality indices regarding the
LSAS was due to improved estimation of centrality indices or
reduced utility of infrequency estimates from the expanded version
of Sample A. We therefore also ran this regression using the
original Sample A infrequency and SD estimates. In this analysis,
infrequency did predict regarding the LSAS at about the same
level as centrality (infrequency: part r  .46, p  .006; central-
ity: part r  .44, p  .009 after correction for SDBeta), but the
evidence for centrality indices remained more convincing than in
the primary analyses. There was thus some evidence that centrality
performed more in keeping with hypothesis when the sample was
not restricted to participants who are expected to score high on the
LSAS, but this improvement was not seen for measures other than
the LSAS, where infrequency continued to show the strongest
associations. Infrequency, in contrast, showed stronger associa-
tions when estimated based on GSAD participants alone.
Nodes of particular interest. The nodes with highest central-
ity, based on the z-scored and combined centrality composite from
the expanded Sample A analysis were (a) the combined Situations
11 and 12 (talking with unfamiliar people), (b) Situation 15 (center
of attention), and (c) Situation 7 (going to a party). The least
central were (a) Situation 17 (test-taking), (b) Situation 21 (asking
someone on a date), and (c) Situation 1 (telephoning). The nodes
with the lowest infrequency from the primary analyses were (a) the
combined Situations 6 and 20 (public speaking or performance),
(b) Situation 16 (commenting during a meeting), and (c) Situation
15 (center of attention). The nodes with the highest infreqency
were (a) Situation 13 (urinating in restroom), (b) Situation 4
(drinking in public), and (c) Situation 9 (writing while observed).
Node values on specific centrality indices, as well as the different
versions of each variable, can be obtained through examination of
the data in Supplemental Table S1 in the online supplementary
material.
Discussion
We sought to determine whether central symptoms identified
via network analysis of cross-sectional data would predict the
correlation between change in a given node and change in other
symptoms across treatment in a second dataset. We hypothesized
that items identified as highly central in the LSAS would have a
stronger ability to predict change of symptoms across treatment, in
accordance with other suggestions in the literature (McNally et al.,
2015; Ruzzano et al., 2015). We found that centrality did predict
which nodes were more strongly associated with change above and
beyond other predictors. However, this prediction was restricted
entirely to the LSAS itself. LSAS nodes with higher centrality
indices showed no promise as useful indicators of change in other
measures of social anxiety severity. In contrast, how frequently
items were endorsed showed a more consistent ability to predict
node importance, both within the LSAS and in extension to other
measures. Nodes that were more frequently endorsed were much
more likely to show signs of being influential across treatment.
What do our results suggest about the assertion that centrality
from a cross-sectional network is a good guide to determining
which symptoms are important to focus on in treatment? Our
findings clearly run counter to the pessimistic view that centrality
indices from cross-sectional data would tell us nothing about
associations over time. An optimistic reading of our results might
conclude that centrality indices, and particularly strength (a more
stable index), might provide some information about which symp-
toms are more important for treatment. Higher centrality in our
data was indeed associated with a stronger association with change
across the entire LSAS network: Targeting the highly central
symptoms might therefore promote generalization of treatment
gains across the LSAS as a whole. Clinical scientists might there-
fore take our results as license to interpret existing centrality
findings as indicating good targets for treatment. However, there
are at least three caveats to this conclusion.
Caveat 1: Select Items With Care
First, our results imply that simply analyzing the items of a
given measure may not produce such promising results unless care
is taken in determining in selecting nodes for the network analyses.
Our initial results obtained by simply analyzing all of the items
(see the online supplemental material) seemed to indicate that
centrality indices were conflated with infrequency of endorsement,
whereas our revised analyses did not indicate this was the case.
Avoiding very high correlations among nodes appeared to ame-
liorate the effects of infrequency of endorsement on the network.
Perhaps importantly, the LSAS is a frequently used measure that is
widely regarded as having great clinical utility based on a strong
evidence base for its validity in measuring symptoms of SAD (see
Fresco et al., 2001 for a review). Unfortunately, analyzing the
individual items of this arguably gold-standard measure proved
inadvisable due to very high correlations among fear and avoid-
ance nodes that represented the same situation. Deciding in what
form to include items to avoid nonsensical results took consider-






































































































839CENTRALITY FROM CROSS-SECTIONAL NETWORKS
who may be inclined to analyze the items of a measure without
consideration of item properties and intercorrelations, a method
that might seem to be endorsed by early demonstrations of network
analysis focused on psychopathology (cf. Fried & Cramer, 2017).
To the extent that other researchers have followed these early
examples, clinicians and researchers should take care in interpret-
ing published findings regarding centrality indices. For example,
during the review process for this article we became aware of two
network analyses focusing on the LSAS (Heeren, Jones, & Mc-
Nally, 2018; Heeren & McNally, 2018), one of which (Heeren &
McNally, 2018) focused on the LSAS alone, as we did here. These
researchers indeed followed the same procedure typically used in
previous network analyses: All items were included in the network
in their original form. We contacted the authors (Heeren & Mc-
Nally), who confirmed that their data produce the same error
message we received (i.e., a warning regarding a nonpositive
definite matrix) when the data are analyzed using the same method
we used (A. Heeren, personal communication, June 7 and June 13,
2018).3 We expect that even in cases in which the statistical error
does not arise, the conceptual problem of including multiple nodes
that measure the same construct may be common. The clinical
scientist who is inclined to interpret centrality indices optimisti-
cally as a result of our results should be aware that many research-
ers in the area have only recently begun to consider that it may not
be optimal to include all items on a measure as separate nodes in
analysis.
Caveat 2: The Importance of Item Properties
Second, our evidence indicated a medium-to-large effect for cen-
trality, whereas infrequency generally showed larger effects. Some
readers might object that there is no reason for the “whereas” in the
previous sentence: It should be no surprise that floor effects are
important. However, it may be a surprise to clinicians to find that our
positive results for centrality indices come with the context that it
would be even better to treat common symptoms (which, arguably,
existing treatments tend to focus on already). Of course, our results
indicate that it would be an even better idea to use both indices to
select items: That is, clinicians could treat select symptoms on the
basis of both centrality and frequency of endorsement. We are of two
minds on this point; some of the current authors see no contradiction
between centrality indices and floor effects having an influence on
results. For some of the current authors, however, this situation is
unsatisfying because it indicates that relatively superficial item prop-
erties may be more important, in some instances, than centrality
indices derived from sophisticated analyses that researchers and cli-
nicians hope will uncover causal processes. Of course, it remains
possible that the highly endorsed items play an important causal role.
It could be the case that fear of giving presentations has a unique
causal role for SAD; we simply cannot separate any such causal role
from the item properties given our data. We do believe, however, that
our results can serve as a warning (that echoes those of other authors,
e.g., Terluin et al., 2016) to researchers to examine the issue of item
properties, such as endorsement rates, when conducting any statistical
analysis, including network analysis.
In network analysis, the typical current practice is to examine
sets of single item scores as if items themselves measure constructs
directly. This practice maximizes the chances that results could be
influenced by relatively superficial item properties. We have
shown in this paper, however, that careful examination of items
can help reduce this possibility. It may also be useful to reexamine
the latent variable models that served as the spur to move in a
different direction (cf. Fried & Cramer, 2017). We say this because
latent variables provide a method to combine multiple items based
on their inferred relationship with the underlying variable that is
being measured. This property of latent variables cannot com-
pletely eliminate the influence of factors such as floor effects, but
it can at least reduce that influence. Indeed, we arguably accom-
plished a similar goal in a less precise way here by combining
items. A rapprochement between latent variable models and net-
work analyses may be fruitful, as has been previously suggested
(Fried & Cramer, 2017). Epskamp and colleagues have recently
presented an approach that allows a combination of the two meth-
ods, although multiple challenges remain (Epskamp, Rhemtulla, &
Borsboom, 2017). An alternative would be to develop measures
that are free of floor or ceiling effects, but we have no optimism
that this will be accomplished soon for the measurement of clinical
problems.
Caveat 3: The Gates of Causality
There remains a third caveat for those who might take our
results as indicating that cross-sectional networks will yield infor-
mative centrality indices. Centrality indices showed no ability to
detect items that showed influence outside of the LSAS, whereas
frequency of item endorsement did. This puts a reader inclined
to an optimistic reading in an awkward position. Centrality seems
to identify important LSAS items, but only within the wall, so to
speak, of the LSAS itself. Accepting this result as evidence of the
importance of centrality indices would require the reader to also
accept that our results imply that importance stops at the gates of
the LSAS. This conclusion seems awkward to us because the other
measures assess constructs that should be close neighbors to the
constructs assessed by the LSAS. For example, the LSAS includes
items assessing social interaction anxiety: Why, then, should cen-
trality not also identify items showing signs of greater influence on
the SIAS-S, a unifactorial measure of social interaction anxiety?
Although we have thought of answers for that question, none of the
answers are particularly satisfying or explain how centrality indi-
ces can index important causal processes and still provide the
current result. For example, centrality might identify which items
are most heavily saturated with variance that is unique to the
LSAS, such as some form of method variance that remained
consistent across Sample A and Sample B. For example, both
versions of the LSAS used include a specific instruction to focus
on the past week; the other measures we examined do not.4
Whether due to the focus on the past week or for some other reason
3 We are grateful to the authors for their speedy and open discussion of
this issue. At the time of this writing, the authors are working with the
editor of the journal to publish an erratum.
4 The SDS, however, implies a focus on the past week (by including an
option to check a box indicating that one was out of work for the past week
for reasons other than the disorder) without specific instructions to that
effect. One might therefore argue that the SDS should contain similar
method variance. However, as can be seen in Table 2, the results from the
SDS could be interpreted as being more positive regarding centrality than
for the other measures. Thus, the possibility that this method issue is






































































































840 RODEBAUGH ET AL.
related to method variance unique to the LSAS, the result we
obtained would be expected: The highly central items are impor-
tant within the LSAS, but not outside of it (unless another measure
shares that method component). The point is that it is difficult to
rectify centrality as an important index of causality with an effect
that ends at the gates of a specific measure. On the other hand, it
may be possible to read these results optimistically, as an indica-
tion that networks should contain the entire set of variables in-
volved in a causal network. From this point of view, the problem
is that only the LSAS was included in the network.
Limitations and Future Directions
Our initial results were vulnerable to several concerns: (a) the
network may have been affected by relatively superficial item
properties (such as infrequency and variance); (b) the network may
have varied meaningfully from the network that would have been
estimated from the smaller pretreatment dataset, such that the
pretreatment network would produce more useful estimates; and
(c) the network may have been affected by the selection of GSAD
participants. Our follow-up tests provided clarity: Only the addi-
tion of participants who did not have GSAD resulted in any sign of
improved prediction for centrality indices, and even in this case
infrequency remained a more robust predictor (at least outside of
the LSAS network). Thus, none of these concerns appear to
explain the effects observed.
We believe that the most important limitation of our work is that
we did not select symptoms for specific intervention and test the
resulting changes in a network when those symptoms are targeted
(in comparison to when other symptoms are targeted). That sce-
nario is clearly the desired goal of network analyses that many
researchers have referred to. We focused on tests that were plau-
sible and possible given available data; further, we tested a logical
extension of the idea that centrality indices will identify key
symptoms for treatment. Clearly, however, direct tests of randomly
assigned interventions at the symptom level are sorely needed. One
advantage of such direct tests is that they would provide the ability
for true prospective tests of centrality indices. Here, we were
limited to testing whether centrality was correlated with how
change in nodes correlated with change in other nodes and mea-
sures. Although these analyses involved time, they do not repre-
sent fully prospective prediction, which would be preferable.
Among other reasons, fully prospective prediction with random
assignment to a meaningful control condition would allow one to
rule out regression to the mean as a competing explanation.
Notably, our findings, even if replicated, do not rule out the
possibility that there might be some instances in which cross-
sectional networks offer important information about symptoms
that are key to changing not only that network, but beyond.
Perhaps social anxiety symptoms, or the LSAS items, in particular,
are very different from other types of symptoms, and centrality
indices from cross-sectional networks for another disorder would
show different properties. Although the extent to which cross-
sectional data have meaning for causality is complex and conten-
tious, some authors have proposed situations under which cross-
sectional data should be expected to yield causal insights (Pearl,
2000). In brief, among other conditions, the modeling strategy of
directed acyclic graphs presented by Pearl requires that there
cannot be feedback loops or vicious circles; more generally, only
one direction of effect can be modeled between two variables in
cross-sectional data (if A causes B, B cannot cause A). Pearl’s
approach also assumes all important variables in the causal system
are included in the network. It is unclear to us whether clinical
researchers generally consider these issues regarding cross-
sectional data, but it is possible that giving them greater attention
(cf. Morgan & Winship, 2015; Pearl, 2000) might lead to more
positive results. Notably, however, one or two sets of psycholog-
ical symptoms (i.e., the typical focus of most network analysis
papers thus far) do not seem like plausible candidates for a set of
variables that would satisfy these conditions.
Some additional concerns are worth discussing. First, although
our samples were large and reasonably diverse, greater diversity
(e.g., racial diversity) would have been desirable. Second, we do
not believe the kind of data examined here would ever be expected
to hold to the conditions that have been suggested as necessary for
cross-sectional data to comment on causality, but in theory the
measurement could have been improved to increase applicability.
For example, the full range of theorized causes of social anxiety
could have been included in the model, rather than social anxiety
symptoms alone. That said, our examination was focused on
determining whether currently common network analyses would
be successful in determining key symptoms, and the available
networks rarely move beyond the confines of symptoms of one or
two disorders. Finally, there are other centrality indices available
(e.g., Haslbeck & Fried, 2017), and we are aware of others that are
under development. It is always possible that these indices will
prove more useful, although we encourage skepticism given our
current results.
Conclusions
Keeping those limitations in mind, we have several recommen-
dations for treatment providers and treatment outcome researchers.
First, we suggest caution in interpreting existing networks using
cross-sectional data as indicating important symptoms that should
be focused on in treatment. It remains possible that some published
networks might eventually be shown to have pointed in a useful
direction, but our data clearly indicate that cross-sectional net-
works, even in a large dataset, cannot always be taken as a clear
indicator of symptoms that are important in predicting change
across treatment for symptoms overall (as opposed to the specific
items used for analysis). Of note, attempting to find one or two
most central symptoms to focus on gains even less support from
our analyses, which (a) focused on centrality indices as continuous
variables (i.e., not one or two most central symptoms) and (b)
revealed that, unsurprisingly, the precise symptoms that were most
central varied by analysis, sample, and centrality index (see Sup-
plemental Table S1 in the online supplemental material).
Second, for those instances in which researchers wish to focus
on cross-sectional data to inform treatment research, we urge them
to carefully consider whether their data and methods are consistent
with the recommendations of theorists who at least find it plausible
that this is a fruitful exercise (e.g., Pearl, 2000). Third, we note that
longitudinal and experimental network analysis studies are far
rarer than cross-sectional studies at this time. This imbalance in the
literature is unfortunate: Causal relationships might be better ad-
dressed using a combination of longitudinal (i.e., both in groups of
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networks of symptoms (cf. Fried & Cramer, 2017) alongside
carefully conducted tests in cross-sectional data. This call has been
made before in regard to network analysis (e.g., Borsboom, &
Cramer, 2013; van de Leemput et al., 2014, among others), but we
believe the call should be repeated. Longitudinal and experimental
studies are difficult and expensive, but they may be our best hope
for discovering symptoms that are actually crucial for intervention:
We would have to devote more attention to such studies to fully
evaluate their promise.
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